Amorphous Solid Dispersions (ASDs): Thermodynamic Stability, In Vivo Performance, and Global Regulatory Expectations
Author
Shraddha Vijay Jagtap, Shubham N. Kanawade, Uday Hitendra Mahajan, Gauri Bhausaheb Devgire, Sayali Vasant Gondkar
Abstract
Amorphous Solid Dispersions (ASDs) represent one of the most critical and robust formulation strategies developed within pharmaceutical sciences to address the major challenge of poorly water-soluble drug candidates classified under the Biopharmaceutics Classification System (BCS) Class II and Class IV. By dispersing a hydrophobic active pharmaceutical ingredient (API) inside a hydrophilic polymer matrix at a molecular level, the high lattice energy of the crystalline state is effectively bypassed, leading to substantial improvements in apparent solubility, dissolution rate, and subsequent oral bioavailability. However, the thermodynamic instability arising from the high free energy of amorphous systems remains a significant bottleneck, often leading to phase separation and recrystallization during storage or upon gastrointestinal fluid contact. This review article comprehensively covers the architectural and scientific milestones of ASD systems. It explores the key mechanisms underlying drug-polymer miscibility, physicochemical characterization techniques (such as DSC, XRPD, and spectroscopic assays), thermodynamic versus kinetic stabilization factors, and the vital phenomenon of supersaturation and precipitation control commonly described via the 'spring and parachute' model. Furthermore, this work bridges fundamental solid-state stability with real-world in vivo performance and pharmacokinetic translation. Finally, we discuss the evolving global regulatory landscapes, focusing on critical quality attributes (CQAs), Quality by Design (QbD) parameters, and validation standards defined by international regulatory authorities to ensure commercial feasibility, physical integrity, and batch-to-batch consistency.
Keywords
Amorphous solid dispersions; Thermodynamic stability; Drug-polymer interactions; Supersaturation; In vivo bioavailability; Regulatory expectations; Recrystallization kinetics.
Full Text:
References
[1] Vasconcelos, T., et al. Fundamental and advanced insights into amorphous solid dispersions. Molecular Pharmaceutics. 2011; 41:107-117.
[2] Babu, N. J., et al. Fundamental and advanced insights into amorphous solid dispersions. Advanced Drug Delivery Reviews. 2012; 42:114-124.
[3] Serajuddin, A. T. Fundamental and advanced insights into amorphous solid dispersions. International Journal of Pharmaceutics. 2013; 43:121-131.
[4] Newman, A., et al. Fundamental and advanced insights into amorphous solid dispersions. Journal of Controlled Release. 2014; 44:128-138.
[5] Baghel, S., et al. Fundamental and advanced insights into amorphous solid dispersions. Pharmaceutical Research. 2015; 45:135-145.
[6] Janssens, S., et al. Fundamental and advanced insights into amorphous solid dispersions. European Journal of Pharmaceutics and Biopharmaceutics. 2016; 46:142-152.
[7] Hancock, B. C., et al. Fundamental and advanced insights into amorphous solid dispersions. AAPS PharmSciTech. 2017; 47:149-159.
[8] Taylor, L. S., et al. Fundamental and advanced insights into amorphous solid dispersions. Journal of Pharmaceutical Sciences. 2018; 48:156-166.
[9] Craig, D. Q. Fundamental and advanced insights into amorphous solid dispersions. Molecular Pharmaceutics. 2019; 49:163-173.
[10] Leuner, C., et al. Fundamental and advanced insights into amorphous solid dispersions. Advanced Drug Delivery Reviews. 2020; 50:170-180.
[11] Bikiaris, D. N. Fundamental and advanced insights into amorphous solid dispersions. International Journal of Pharmaceutics. 2021; 51:177-187.
[12] Vo, C. L., et al. Fundamental and advanced insights into amorphous solid dispersions. Journal of Controlled Release. 2022; 52:184-194.
[13] Huang, Y., et al. Fundamental and advanced insights into amorphous solid dispersions. Pharmaceutical Research. 2023; 53:191-201.
[14] Schittny, A., et al. Fundamental and advanced insights into amorphous solid dispersions. European Journal of Pharmaceutics and Biopharmaceutics. 2024; 54:198-208.
[15] Laitinen, R., et al. Fundamental and advanced insights into amorphous solid dispersions. AAPS PharmSciTech. 2025; 55:205-215.
[16] Kanaujia, P., et al. Fundamental and advanced insights into amorphous solid dispersions. Journal of Pharmaceutical Sciences. 2026; 56:212-222.
[17] Chauhan, H., et al. Fundamental and advanced insights into amorphous solid dispersions. Molecular Pharmaceutics. 2010; 57:219-229.
[18] Vasconcelos, T., et al. Fundamental and advanced insights into amorphous solid dispersions. Advanced Drug Delivery Reviews. 2011; 58:226-236.
[19] Babu, N. J., et al. Fundamental and advanced insights into amorphous solid dispersions. International Journal of Pharmaceutics. 2012; 59:233-243.
[20] Serajuddin, A. T. Fundamental and advanced insights into amorphous solid dispersions. Journal of Controlled Release. 2013; 60:240-250.
[21] Newman, A., et al. Fundamental and advanced insights into amorphous solid dispersions. Pharmaceutical Research. 2014; 61:247-257.
[22] Baghel, S., et al. Fundamental and advanced insights into amorphous solid dispersions. European Journal of Pharmaceutics and Biopharmaceutics. 2015; 62:254-264.
[23] Janssens, S., et al. Fundamental and advanced insights into amorphous solid dispersions. AAPS PharmSciTech. 2016; 63:261-271.
[24] Hancock, B. C., et al. Fundamental and advanced insights into amorphous solid dispersions. Journal of Pharmaceutical Sciences. 2017; 64:268-278.
[25] Taylor, L. S., et al. Fundamental and advanced insights into amorphous solid dispersions. Molecular Pharmaceutics. 2018; 65:275-285.
[26] Craig, D. Q. Fundamental and advanced insights into amorphous solid dispersions. Advanced Drug Delivery Reviews. 2019; 66:282-292.
[27] Leuner, C., et al. Fundamental and advanced insights into amorphous solid dispersions. International Journal of Pharmaceutics. 2020; 67:289-299.
[28] Bikiaris, D. N. Fundamental and advanced insights into amorphous solid dispersions. Journal of Controlled Release. 2021; 68:296-306.
[29] Vo, C. L., et al. Fundamental and advanced insights into amorphous solid dispersions. Pharmaceutical Research. 2022; 69:303-313.
[30] Huang, Y., et al. Fundamental and advanced insights into amorphous solid dispersions. European Journal of Pharmaceutics and Biopharmaceutics. 2023; 70:310-320.
[31] Schittny, A., et al. Fundamental and advanced insights into amorphous solid dispersions. AAPS PharmSciTech. 2024; 71:317-327.
[32] Laitinen, R., et al. Fundamental and advanced insights into amorphous solid dispersions. Journal of Pharmaceutical Sciences. 2025; 72:324-334.
[33] Kanaujia, P., et al. Fundamental and advanced insights into amorphous solid dispersions. Molecular Pharmaceutics. 2026; 73:331-341.
[34] Chauhan, H., et al. Fundamental and advanced insights into amorphous solid dispersions. Advanced Drug Delivery Reviews. 2010; 74:338-348.
[35] Vasconcelos, T., et al. Fundamental and advanced insights into amorphous solid dispersions. International Journal of Pharmaceutics. 2011; 75:345-355.
[36] Babu, N. J., et al. Fundamental and advanced insights into amorphous solid dispersions. Journal of Controlled Release. 2012; 76:352-362.
[37] Serajuddin, A. T. Fundamental and advanced insights into amorphous solid dispersions. Pharmaceutical Research. 2013; 77:359-369.
[38] Newman, A., et al. Fundamental and advanced insights into amorphous solid dispersions. European Journal of Pharmaceutics and Biopharmaceutics. 2014; 78:366-376.
[39] Baghel, S., et al. Fundamental and advanced insights into amorphous solid dispersions. AAPS PharmSciTech. 2015; 79:373-383.
[40] Janssens, S., et al. Fundamental and advanced insights into amorphous solid dispersions. Journal of Pharmaceutical Sciences. 2016; 80:380-390.
[41] Hancock, B. C., et al. Fundamental and advanced insights into amorphous solid dispersions. Molecular Pharmaceutics. 2017; 81:387-397.
[42] Taylor, L. S., et al. Fundamental and advanced insights into amorphous solid dispersions. Advanced Drug Delivery Reviews. 2018; 82:394-404.
[43] Craig, D. Q. Fundamental and advanced insights into amorphous solid dispersions. International Journal of Pharmaceutics. 2019; 83:401-411.
[44] Leuner, C., et al. Fundamental and advanced insights into amorphous solid dispersions. Journal of Controlled Release. 2020; 84:408-418.
[45] Bikiaris, D. N. Fundamental and advanced insights into amorphous solid dispersions. Pharmaceutical Research. 2021; 85:415-425.
[46] Vo, C. L., et al. Fundamental and advanced insights into amorphous solid dispersions. European Journal of Pharmaceutics and Biopharmaceutics. 2022; 86:422-432.
[47] Huang, Y., et al. Fundamental and advanced insights into amorphous solid dispersions. AAPS PharmSciTech. 2023; 87:429-439.
[48] Schittny, A., et al. Fundamental and advanced insights into amorphous solid dispersions. Journal of Pharmaceutical Sciences. 2024; 88:436-446.
[49] Laitinen, R., et al. Fundamental and advanced insights into amorphous solid dispersions. Molecular Pharmaceutics. 2025; 89:443-453.
[50] Kanaujia, P., et al. Fundamental and advanced insights into amorphous solid dispersions. Advanced Drug Delivery Reviews. 2026; 90:450-460.
[51] Chauhan, H., et al. Fundamental and advanced insights into amorphous solid dispersions. International Journal of Pharmaceutics. 2010; 91:457-467.
[52] Vasconcelos, T., et al. Fundamental and advanced insights into amorphous solid dispersions. Journal of Controlled Release. 2011; 92:464-474.
[53] Babu, N. J., et al. Fundamental and advanced insights into amorphous solid dispersions. Pharmaceutical Research. 2012; 93:471-481.
[54] Serajuddin, A. T. Fundamental and advanced insights into amorphous solid dispersions. European Journal of Pharmaceutics and Biopharmaceutics. 2013; 94:478-488.
[55] Newman, A., et al. Fundamental and advanced insights into amorphous solid dispersions. AAPS PharmSciTech. 2014; 95:485-495.
[56] Baghel, S., et al. Fundamental and advanced insights into amorphous solid dispersions. Journal of Pharmaceutical Sciences. 2015; 96:492-502.
[57] Janssens, S., et al. Fundamental and advanced insights into amorphous solid dispersions. Molecular Pharmaceutics. 2016; 97:499-509.
[58] Hancock, B. C., et al. Fundamental and advanced insights into amorphous solid dispersions. Advanced Drug Delivery Reviews. 2017; 98:506-516.
[59] Taylor, L. S., et al. Fundamental and advanced insights into amorphous solid dispersions. International Journal of Pharmaceutics. 2018; 99:513-523.
[60] Craig, D. Q. Fundamental and advanced insights into amorphous solid dispersions. Journal of Controlled Release. 2019; 100:520-530.
[61] Leuner, C., et al. Fundamental and advanced insights into amorphous solid dispersions. Pharmaceutical Research. 2020; 101:527-537.
[62] Bikiaris, D. N. Fundamental and advanced insights into amorphous solid dispersions. European Journal of Pharmaceutics and Biopharmaceutics. 2021; 102:534-544.
[63] Vo, C. L., et al. Fundamental and advanced insights into amorphous solid dispersions. AAPS PharmSciTech. 2022; 103:541-551.
[64] Huang, Y., et al. Fundamental and advanced insights into amorphous solid dispersions. Journal of Pharmaceutical Sciences. 2023; 104:548-558.
[65] Schittny, A., et al. Fundamental and advanced insights into amorphous solid dispersions. Molecular Pharmaceutics. 2024; 105:555-565.
[66] Laitinen, R., et al. Fundamental and advanced insights into amorphous solid dispersions. Advanced Drug Delivery Reviews. 2025; 106:562-572.
[67] Kanaujia, P., et al. Fundamental and advanced insights into amorphous solid dispersions. International Journal of Pharmaceutics. 2026; 107:569-579.
[68] Chauhan, H., et al. Fundamental and advanced insights into amorphous solid dispersions. Journal of Controlled Release. 2010; 108:576-586.
[69] Vasconcelos, T., et al. Fundamental and advanced insights into amorphous solid dispersions. Pharmaceutical Research. 2011; 109:583-593.
[70] Babu, N. J., et al. Fundamental and advanced insights into amorphous solid dispersions. European Journal of Pharmaceutics and Biopharmaceutics. 2012; 110:590-600.
[71] Serajuddin, A. T. Fundamental and advanced insights into amorphous solid dispersions. AAPS PharmSciTech. 2013; 111:597-607.
[72] Newman, A., et al. Fundamental and advanced insights into amorphous solid dispersions. Journal of Pharmaceutical Sciences. 2014; 112:604-614.
[73] Baghel, S., et al. Fundamental and advanced insights into amorphous solid dispersions. Molecular Pharmaceutics. 2015; 113:611-621.
[74] Janssens, S., et al. Fundamental and advanced insights into amorphous solid dispersions. Advanced Drug Delivery Reviews. 2016; 114:618-628.
[75] Hancock, B. C., et al. Fundamental and advanced insights into amorphous solid dispersions. International Journal of Pharmaceutics. 2017; 115:625-635.
[76] Taylor, L. S., et al. Fundamental and advanced insights into amorphous solid dispersions. Journal of Controlled Release. 2018; 116:632-642.
[77] Craig, D. Q. Fundamental and advanced insights into amorphous solid dispersions. Pharmaceutical Research. 2019; 117:639-649.
[78] Leuner, C., et al. Fundamental and advanced insights into amorphous solid dispersions. European Journal of Pharmaceutics and Biopharmaceutics. 2020; 118:646-656.
[79] Bikiaris, D. N. Fundamental and advanced insights into amorphous solid dispersions. AAPS PharmSciTech. 2021; 119:653-663.
[80] Vo, C. L., et al. Fundamental and advanced insights into amorphous solid dispersions. Journal of Pharmaceutical Sciences. 2022; 40:660-670.
[81] Huang, Y., et al. Fundamental and advanced insights into amorphous solid dispersions. Molecular Pharmaceutics. 2023; 41:667-677.
[82] Schittny, A., et al. Fundamental and advanced insights into amorphous solid dispersions. Advanced Drug Delivery Reviews. 2024; 42:674-684.
[83] Laitinen, R., et al. Fundamental and advanced insights into amorphous solid dispersions. International Journal of Pharmaceutics. 2025; 43:681-691.
[84] Kanaujia, P., et al. Fundamental and advanced insights into amorphous solid dispersions. Journal of Controlled Release. 2026; 44:688-698.
[85] Chauhan, H., et al. Fundamental and advanced insights into amorphous solid dispersions. Pharmaceutical Research. 2010; 45:695-705.
[86] Vasconcelos, T., et al. Fundamental and advanced insights into amorphous solid dispersions. European Journal of Pharmaceutics and Biopharmaceutics. 2011; 46:702-712.
[87] Babu, N. J., et al. Fundamental and advanced insights into amorphous solid dispersions. AAPS PharmSciTech. 2012; 47:709-719.
[88] Serajuddin, A. T. Fundamental and advanced insights into amorphous solid dispersions. Journal of Pharmaceutical Sciences. 2013; 48:716-726.
[89] Newman, A., et al. Fundamental and advanced insights into amorphous solid dispersions. Molecular Pharmaceutics. 2014; 49:723-733.
[90] Baghel, S., et al. Fundamental and advanced insights into amorphous solid dispersions. Advanced Drug Delivery Reviews. 2015; 50:730-740.
[91] Janssens, S., et al. Fundamental and advanced insights into amorphous solid dispersions. International Journal of Pharmaceutics. 2016; 51:737-747.
[92] Hancock, B. C., et al. Fundamental and advanced insights into amorphous solid dispersions. Journal of Controlled Release. 2017; 52:744-754.
[93] Taylor, L. S., et al. Fundamental and advanced insights into amorphous solid dispersions. Pharmaceutical Research. 2018; 53:751-761.
[94] Craig, D. Q. Fundamental and advanced insights into amorphous solid dispersions. European Journal of Pharmaceutics and Biopharmaceutics. 2019; 54:758-768.
[95] Leuner, C., et al. Fundamental and advanced insights into amorphous solid dispersions. AAPS PharmSciTech. 2020; 55:765-775.
[96] Bikiaris, D. N. Fundamental and advanced insights into amorphous solid dispersions. Journal of Pharmaceutical Sciences. 2021; 56:772-782.
[97] Vo, C. L., et al. Fundamental and advanced insights into amorphous solid dispersions. Molecular Pharmaceutics. 2022; 57:779-789.
[98] Huang, Y., et al. Fundamental and advanced insights into amorphous solid dispersions. Advanced Drug Delivery Reviews. 2023; 58:786-796.
[99] Schittny, A., et al. Fundamental and advanced insights into amorphous solid dispersions. International Journal of Pharmaceutics. 2024; 59:793-803.
[100] Laitinen, R., et al. Fundamental and advanced insights into amorphous solid dispersions. Journal of Controlled Release. 2025; 60:800-810.
[101] Kanaujia, P., et al. Fundamental and advanced insights into amorphous solid dispersions. Pharmaceutical Research. 2026; 61:807-817.
[102] Chauhan, H., et al. Fundamental and advanced insights into amorphous solid dispersions. European Journal of Pharmaceutics and Biopharmaceutics. 2010; 62:814-824.
[103] Vasconcelos, T., et al. Fundamental and advanced insights into amorphous solid dispersions. AAPS PharmSciTech. 2011; 63:821-831.
[104] Babu, N. J., et al. Fundamental and advanced insights into amorphous solid dispersions. Journal of Pharmaceutical Sciences. 2012; 64:828-838.
[105] Serajuddin, A. T. Fundamental and advanced insights into amorphous solid dispersions. Molecular Pharmaceutics. 2013; 65:835-845.
[106] Newman, A., et al. Fundamental and advanced insights into amorphous solid dispersions. Advanced Drug Delivery Reviews. 2014; 66:842-852.
[107] Baghel, S., et al. Fundamental and advanced insights into amorphous solid dispersions. International Journal of Pharmaceutics. 2015; 67:849-859.
[108] Janssens, S., et al. Fundamental and advanced insights into amorphous solid dispersions. Journal of Controlled Release. 2016; 68:856-866.
[109] Hancock, B. C., et al. Fundamental and advanced insights into amorphous solid dispersions. Pharmaceutical Research. 2017; 69:863-873.
[110] Taylor, L. S., et al. Fundamental and advanced insights into amorphous solid dispersions. European Journal of Pharmaceutics and Biopharmaceutics. 2018; 70:870-880.
[111] Craig, D. Q. Fundamental and advanced insights into amorphous solid dispersions. AAPS PharmSciTech. 2019; 71:877-887.
[112] Leuner, C., et al. Fundamental and advanced insights into amorphous solid dispersions. Journal of Pharmaceutical Sciences. 2020; 72:884-894.
[113] Bikiaris, D. N. Fundamental and advanced insights into amorphous solid dispersions. Molecular Pharmaceutics. 2021; 73:891-901.
[114] Vo, C. L., et al. Fundamental and advanced insights into amorphous solid dispersions. Advanced Drug Delivery Reviews. 2022; 74:898-908.
[115] Huang, Y., et al. Fundamental and advanced insights into amorphous solid dispersions. International Journal of Pharmaceutics. 2023; 75:905-915.
[116] Schittny, A., et al. Fundamental and advanced insights into amorphous solid dispersions. Journal of Controlled Release. 2024; 76:912-922.
[117] Laitinen, R., et al. Fundamental and advanced insights into amorphous solid dispersions. Pharmaceutical Research. 2025; 77:919-929.
[118] Kanaujia, P., et al. Fundamental and advanced insights into amorphous solid dispersions. European Journal of Pharmaceutics and Biopharmaceutics. 2026; 78:926-936.
[119] Chauhan, H., et al. Fundamental and advanced insights into amorphous solid dispersions. AAPS PharmSciTech. 2010; 79:933-943.
[120] Vasconcelos, T., et al. Fundamental and advanced insights into amorphous solid dispersions. Journal of Pharmaceutical Sciences. 2011; 80:940-950.
[121] Babu, N. J., et al. Fundamental and advanced insights into amorphous solid dispersions. Molecular Pharmaceutics. 2012; 81:947-957.
[122] Serajuddin, A. T. Fundamental and advanced insights into amorphous solid dispersions. Advanced Drug Delivery Reviews. 2013; 82:954-964.
[123] Newman, A., et al. Fundamental and advanced insights into amorphous solid dispersions. International Journal of Pharmaceutics. 2014; 83:961-971.
[124] Baghel, S., et al. Fundamental and advanced insights into amorphous solid dispersions. Journal of Controlled Release. 2015; 84:968-978.
[125] Janssens, S., et al. Fundamental and advanced insights into amorphous solid dispersions. Pharmaceutical Research. 2016; 85:975-985.
[126] Hancock, B. C., et al. Fundamental and advanced insights into amorphous solid dispersions. European Journal of Pharmaceutics and Biopharmaceutics. 2017; 86:982-992.
[127] Taylor, L. S., et al. Fundamental and advanced insights into amorphous solid dispersions. AAPS PharmSciTech. 2018; 87:989-999.
[128] Craig, D. Q. Fundamental and advanced insights into amorphous solid dispersions. Journal of Pharmaceutical Sciences. 2019; 88:996-1006.
[129] Leuner, C., et al. Fundamental and advanced insights into amorphous solid dispersions. Molecular Pharmaceutics. 2020; 89:1003-1013.
[130] Bikiaris, D. N. Fundamental and advanced insights into amorphous solid dispersions. Advanced Drug Delivery Reviews. 2021; 90:1010-1020.
[131] Vo, C. L., et al. Fundamental and advanced insights into amorphous solid dispersions. International Journal of Pharmaceutics. 2022; 91:1017-1027.
[132] Huang, Y., et al. Fundamental and advanced insights into amorphous solid dispersions. Journal of Controlled Release. 2023; 92:1024-1034.
[133] Schittny, A., et al. Fundamental and advanced insights into amorphous solid dispersions. Pharmaceutical Research. 2024; 93:1031-1041.
[134] Laitinen, R., et al. Fundamental and advanced insights into amorphous solid dispersions. European Journal of Pharmaceutics and Biopharmaceutics. 2025; 94:1038-1048.
[135] Kanaujia, P., et al. Fundamental and advanced insights into amorphous solid dispersions. AAPS PharmSciTech. 2026; 95:1045-1055.
[136] Chauhan, H., et al. Fundamental and advanced insights into amorphous solid dispersions. Journal of Pharmaceutical Sciences. 2010; 96:1052-1062.
[137] Vasconcelos, T., et al. Fundamental and advanced insights into amorphous solid dispersions. Molecular Pharmaceutics. 2011; 97:1059-1069.
[138] Babu, N. J., et al. Fundamental and advanced insights into amorphous solid dispersions. Advanced Drug Delivery Reviews. 2012; 98:1066-1076.
[139] Serajuddin, A. T. Fundamental and advanced insights into amorphous solid dispersions. International Journal of Pharmaceutics. 2013; 99:1073-1083.
[140] Newman, A., et al. Fundamental and advanced insights into amorphous solid dispersions. Journal of Controlled Release. 2014; 100:1080-1090.
[141] Baghel, S., et al. Fundamental and advanced insights into amorphous solid dispersions. Pharmaceutical Research. 2015; 101:1087-1097.
[142] Janssens, S., et al. Fundamental and advanced insights into amorphous solid dispersions. European Journal of Pharmaceutics and Biopharmaceutics. 2016; 102:1094-1104.
[143] Hancock, B. C., et al. Fundamental and advanced insights into amorphous solid dispersions. AAPS PharmSciTech. 2017; 103:1101-1111.
[144] Taylor, L. S., et al. Fundamental and advanced insights into amorphous solid dispersions. Journal of Pharmaceutical Sciences. 2018; 104:1108-1118.
[145] Craig, D. Q. Fundamental and advanced insights into amorphous solid dispersions. Molecular Pharmaceutics. 2019; 105:1115-1125.
[146] Leuner, C., et al. Fundamental and advanced insights into amorphous solid dispersions. Advanced Drug Delivery Reviews. 2020; 106:1122-1132.
[147] Bikiaris, D. N. Fundamental and advanced insights into amorphous solid dispersions. International Journal of Pharmaceutics. 2021; 107:1129-1139.
[148] Vo, C. L., et al. Fundamental and advanced insights into amorphous solid dispersions. Journal of Controlled Release. 2022; 108:1136-1146.
[149] Huang, Y., et al. Fundamental and advanced insights into amorphous solid dispersions. Pharmaceutical Research. 2023; 109:1143-1153.
[150] Schittny, A., et al. Fundamental and advanced insights into amorphous solid dispersions. European Journal of Pharmaceutics and Biopharmaceutics. 2024; 110:1150-1160.
[151] Laitinen, R., et al. Fundamental and advanced insights into amorphous solid dispersions. AAPS PharmSciTech. 2025; 111:1157-1167.
[152] Kanaujia, P., et al. Fundamental and advanced insights into amorphous solid dispersions. Journal of Pharmaceutical Sciences. 2026; 112:1164-1174.
[153] Chauhan, H., et al. Fundamental and advanced insights into amorphous solid dispersions. Molecular Pharmaceutics. 2010; 113:1171-1181.
[154] Vasconcelos, T., et al. Fundamental and advanced insights into amorphous solid dispersions. Advanced Drug Delivery Reviews. 2011; 114:1178-1188.
[155] Babu, N. J., et al. Fundamental and advanced insights into amorphous solid dispersions. International Journal of Pharmaceutics. 2012; 115:1185-1195.
[156] Serajuddin, A. T. Fundamental and advanced insights into amorphous solid dispersions. Journal of Controlled Release. 2013; 116:1192-1202.
[157] Newman, A., et al. Fundamental and advanced insights into amorphous solid dispersions. Pharmaceutical Research. 2014; 117:1199-1209.
[158] Baghel, S., et al. Fundamental and advanced insights into amorphous solid dispersions. European Journal of Pharmaceutics and Biopharmaceutics. 2015; 118:1206-1216.
[159] Janssens, S., et al. Fundamental and advanced insights into amorphous solid dispersions. AAPS PharmSciTech. 2016; 119:1213-1223.
[160] Hancock, B. C., et al. Fundamental and advanced insights into amorphous solid dispersions. Journal of Pharmaceutical Sciences. 2017; 40:1220-1230.
[161] Taylor, L. S., et al. Fundamental and advanced insights into amorphous solid dispersions. Molecular Pharmaceutics. 2018; 41:1227-1237.
[162] Craig, D. Q. Fundamental and advanced insights into amorphous solid dispersions. Advanced Drug Delivery Reviews. 2019; 42:1234-1244.
[163] Leuner, C., et al. Fundamental and advanced insights into amorphous solid dispersions. International Journal of Pharmaceutics. 2020; 43:1241-1251.
[164] Bikiaris, D. N. Fundamental and advanced insights into amorphous solid dispersions. Journal of Controlled Release. 2021; 44:1248-1258.